Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ocular surface epithelial cell membrane is a complex lipid bilayer that serves as the primary physical and biological barrier between the eye and the external environment [1]. Composed of phospholipids, cholesterol, and sphingolipids, this bilayer maintains cellular integrity and regulates the transport of solutes and water, which is critical for corneal transparency and visual acuity [2]. In conditions such as Dry Eye Disease (DED) or chemical injury, the lipid bilayer is compromised by hyperosmotic stress and inflammation, leading to increased permeability and cell death [3]. While not a traditional pharmacological target like a receptor or enzyme, it is the functional target for barrier-stabilizing agents, including lipid-based artificial tears and perfluorohexyloctane, which aim to supplement the tear film lipid layer and protect the underlying cell membranes [4]. Additionally, the bilayer is a site of unintended toxicity for ophthalmic preservatives like benzalkonium chloride, which can disrupt the membrane and exacerbate ocular surface disease [5]. Therapeutic strategies often focus on reinforcing this bilayer to prevent the cycle of inflammation and desiccation seen in chronic ocular surface disorders [4]. The integrity of this membrane is often assessed clinically through staining techniques that identify areas of barrier breach [3].
Stabilization of the cellular barrier and reduction of evaporation through the replenishment of surface lipids and protection of the epithelial membrane integrity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular surface epithelial cell membrane.